Browsing Tag
mFlusiva
1 post
Moderna rallies into a landmark FDA advisory vote on its mRNA seasonal flu vaccine
Moderna (MRNA) rallies as an FDA advisory committee weighs its mRNA seasonal flu vaccine mFlusiva, the first such vote, with a decision due August 5. Full analysis.